Skip to Content

M FE4 (Fenofibrate 145 mg)

Pill with imprint M FE4 is White, Elliptical / Oval and has been identified as Fenofibrate 145 mg. It is supplied by Mylan Pharmaceuticals Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M FE4

Fenofibrate 145 mg M FE4 Front
Fenofibrate 145 mg M FE4 Back
Fenofibrate 145 mg M FE4
Fenofibrate 145 mg M FE4

Fenofibrate

Imprint:
M FE4
Strength:
145 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-3066

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide